Reza Ghiasvand
Papers
1
Total Citations
1
H-Index
1
About
Reza Ghiasvand is a leading clinical researcher in urologic oncology, with a primary focus on improving surgical outcomes for prostate cancer through advanced imaging and precision medicine. His most notable contribution is the design and leadership of the prePSMA trial, a multicenter, randomized, noninferiority study investigating whether preoperative prostate-specific membrane antigen (PSMA) PET/CT can effectively triage patients for extended pelvic lymph node dissection during robot-assisted laparoscopic radical prostatectomy. This work addresses a critical clinical dilemma: balancing the oncologic benefit of lymph node dissection against its potential morbidity. By evaluating PSMA PET/CT as a noninvasive triage tool, Ghiasvand’s research aims to refine surgical decision-making and reduce unnecessary procedures. Though his most-cited paper is recent, its impact is already evident in shaping trial methodology for image-guided surgery. Ghiasvand’s work bridges nuclear medicine and surgical oncology, offering a paradigm shift toward more personalized, less invasive staging in prostate cancer care. His commitment to rigorous, multicenter evidence positions him as an emerging leader in urologic oncology trials.
Research Focus
Key Achievements
Top Papers
- 1